Clovis Oncology, Inc.
CLVSDelisted Dec 29, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001466301
Clovis Oncology, Inc. was delisted on Dec 29, 2022; its insiders filed their last Form 4 on Nov 3, 2022; 103 institutions reported holding it in 13F filings for Q3 2022, worth $42.6M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Clovis Oncology, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
CLVS is no longer listed, and 13F filings after Q3 2022 list far fewer holders. See Q3 2022
- Institutional holders
- 2
- −13 vs. Q4 2022
- Shares held
- 36.8K
- −363.8K (−90.8%) vs. Q4 2022
- Total value
- $520.2K
- +$500.1K (+2,491.8%) vs. Q4 2022
- New holders
- 0
- 1 more added
- Sold out
- 13
- 0 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 1 | $11.0K |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 2 | $520.2K |
| Q4 2022 | 15 | $20.1K |
| Q3 2022 | 103 | $42.6M |
| Q2 2022 | 116 | $76.0M |
| Q1 2022 | 153 | $111.7M |
| Q4 2021 | 154 | $176.8M |
| Q3 2021 | 159 | $274.0M |
| Q2 2021 | 161 | $319.9M |
| Q1 2021 | 165 | $347.3M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Clovis Oncology, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Resources Management Corp | 16,795 | $518.0K | 0.10% | +16,545+6,618.0% | Added |
| MAI Capital Management | 20,000 | $2.18K | 0.00% | 00.0% | Unchanged |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −250,200−100.0% | Sold out |
| S&T Bank | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| Wedbush Securities Inc | 0 | $0 | 0.00% | −20,200−100.0% | Sold out |
| Future Financial Wealth Managment LLC | 0 | $0 | 0.00% | −13,500−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −11,980−100.0% | Sold out |
| Quent Capital, LLC | 0 | $0 | 0.00% | −231−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −660−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −375−100.0% | Sold out |
| Kozak & Associates, Inc. | 0 | $0 | 0.00% | −140−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −10,050−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −265−100.0% | Sold out |
| Coppell Advisory Solutions Corp. | 0 | $0 | 0.00% | −265−100.0% | Sold out |